Format

Send to

Choose Destination
J Exp Clin Cancer Res. 2017 Dec 15;36(1):184. doi: 10.1186/s13046-017-0660-8.

Correction to: Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.

Author information

1
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, China.
2
Department of Physiology, Guilin Medical University, Guilin, Guangxi, China.
3
Department of Breast and Thyroid Surgery, First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
4
Department of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi, China.
5
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, 541004, China. chjian80726@163.com.

Abstract

In the publication of this article [1], the molecule weight of GPR30 in figures was incorrectly, this should have been 55 kDa, and not 38 kDa. This has now been included in this erratum.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center